Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation.

Saved in:
Bibliographic Details
Title: Impact of initial biopsy type on the time to final diagnostic biopsy in patients with follicular lymphoma and suspected histologic transformation.
Authors: Mou E; Department of Internal Medicine, Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA, USA.; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA., Falchi L; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sundaram V; Quantitative Science Unit, Stanford University School of Medicine, Palo Alto, CA, USA., Abramson JS; Massachusetts General Hospital, Yawkey Center, Boston, MA, USA., Balassanian R; Department of Pathology, University of California San Francisco, San Francisco, CA, USA., Beygi S; Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA., Fitzpatrick MJ; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Frank AK; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Gupta S; Department of Pathology, University of Virginia, Charlottesville, VA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Lin O; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Reed JR; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.; Department of Pathology, Stanford University, Stanford, CA, USA., Long SR; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.; Department of Pathology, Stanford University, Stanford, CA, USA., Ly A; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Menke JR; Department of Pathology, Stanford University, Stanford, CA, USA., Reed DR; Section of Hematology and Oncology, Wake Forest Baptist Medical Comprehensive Cancer Center.; Division of Hematology and Oncology, University of Virginia, Charlottesville, VA, USA., Ruiz-Cordero R; Department of Pathology, University of California San Francisco, San Francisco, CA, USA., Volaric AK; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pathology, University of Virginia Health System, Charlottesville, VA, USA., Xie Y; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Wang L; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Wen KW; Department of Pathology, University of California San Francisco, San Francisco, CA, USA.; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Zadeh SL; Department of Pathology, University of Virginia, Charlottesville, VA, USA., Natkunam Y; Department of Pathology, Stanford University, Stanford, CA, USA., Cheung MC; Division of Hematology, Sunnybrook Odette Cancer Centre, Toronto, Canada.; Department of Medicine, University of Toronto, Toronto, Canada., Gratzinger D; Department of Pathology, Stanford University, Stanford, CA, USA.; Department of Pathology, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
Corporate Authors: Cyto-Heme Institutional Collaborative (CHIC) consortium
Source: Leukemia & lymphoma [Leuk Lymphoma] 2021 Dec; Vol. 62 (12), pp. 2864-2872. Date of Electronic Publication: 2021 Jun 26.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1029-2403
DOI:10.1080/10428194.2021.1941936